FDA Clearance Tracker · P030053-S065
MENTOR MemoryGel Breast Implants
Last checked: Nov 20, 2026Latest source record: Mar 8, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Mar 8, 2022
Approved
Time to decision
32 days
Received Feb 4, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030053-S065
- Device name
- MENTOR MemoryGel Breast Implants
- Applicant
- Mentor Corp.
- Applicant location
- Irvin, CA
- Received
- Feb 4, 2022
- Decided
- Mar 8, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P030053
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.3540
FDA's approval statement
As written in FDA's record.
Approval of the revised statistical analysis plan (SAP) for the post-approval study (PAS) referenced above. The SAP has been submitted to align with protocol changes approved in amendment 5 (P030053/S063 and P060028/S042).
Source documents
Other decisions for Mentor Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.